HITAP, under the leadership of the National Health Foundation (NHF), Thailand, is partnering with the Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS) and the Mathematical/Economic Modelling Department (MAEMOD) at the Mahidol Oxford Tropical Medicine Research Unit (MORU) as part of the Asia HTA Consortium

(Reuters) – Sanofi’s experimental pill to treat Gaucher disease, a rare inherited condition, has met its main goal in a late-stage trial, the French drugmaker said on Tuesday.Patients treated with the drug, eliglustat tartrate, showed a statistically significant improvement in the size of their sple

(Reuters) – Sanofi’s rare disease unit Genzyme is pulling leukaemia drug Campath to prepare for its launch under a different dosage and as a multiple sclerosis treatment that will be branded as Lemtrada.The withdrawal, meant to prevent the off-label use of Campath as a multiple sclerosis drug, is al

Vietnam visit 30th and 31st May 2017It feels good to see familiar faces when you are in a new place and I felt the same meeting officials from Health Strategy Planning Institution (HSPI), Ministry of Health of Vietnam once again. I had met them earlier during the HTAsiaLink conference held in April

I (the author of the blog) got to learn a lot about three things while discussions on these potential topics were on-going. Firstly, I got to know the uniqueness of the Vietnamese Health System and how they are trying to incorporate HTA and pharmacoeconomics in their current system, secondly I learn

Ryan Jonathan Sitanggang is an International Cooperation Officer (ICO) at the International Unit of the HITAP Foundation. He works on strengthening HTA networks and systems across Asia through initiatives such as the Asia HTA Registry, the HTAsiaLink Strategic Plan, and regional capacity-building. His role includes managing partnerships, coordinati

Before the pandemic, many countries recognized the importance of regional collaboration in preparing for future pandemics, whether within ASEAN or the broader Asua Pacific region. In 2019, the SSHSPH discussed with the DFAT Australia for funding and support to this initiative, and the onset of the p

Yot Teerawattananon programme leader1, Alia Luz project associate2, Churnrurtai Kanchanachitra director, Mahidol University Global Health 3, Sripen Tantivess senior researcher 1, On behalf of the Prince Mahidol Award Conference secretariat 1Health Intervention and Technology Assessment Program (

Risk Factors of Breast Cancer: A Systematic Review and Meta-Analysis Thunyarat Anothaisintawee, MD1, Cholatip Wiratkapun, MD1, Panuwat Lerdsitthichai, MD, MSc1, Vijj Kasamesup, MD, PhD1, Sansanee Wongwaisayawan, MD1, Jiraporn Srinakarin, MD2, Siriporn Hirunpat, MD3, Piyanoot Woodtichartpreech

Cases of drug-resistant tuberculosis (TB) in the UK have risen by over a quarter in the last year, the Health Protection Agency (HPA) has revealed.In 2011, 431 cases did not respond to antibiotic treatment compared to 342 in 2010, the HPA said. About 550 more cases of TB were disgnosed in 2011.The a